
Harold J. Burstein/X
Jun 3, 2025, 09:15
Harold J. Burstein: First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer
Harold J. Burstein, Breast Cancer Specialist and Professor at Harvard Medical School, posted on X:
“The NEJM has published SERENA-6 data ahead of ASCO25 plenary.
Cami joins other SERDS (elacestrant, imlunestrant, vepdegestrant) with activity in ESR1mut BC
Key questions to think about ahead of session:
1. Intensive ctDNA screening of 10 patients to find 1 who might qualify for ‘switching’ based on ESR1mut. Worthwhile?
2. Does switching among asymptomatic patients with no radiological progression make sense when drug could be added later at progression?
3. Is this fundamentally different than switching treatment based on small upticks in serum tumor markers, without overt progression?
4. Adds to data from EMBER-3 that SERD + CDK46i looks to be effective. Is 2nd line CDK46i now the standard?”
Title: First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer
Authors: François-Clément Bidard, Erica L. Mayer, Yeon Hee Park, Wolfgang Janni, Cynthia Ma, Massimo Cristofanilli, Giampaolo Bianchini, Kevin Kalinsky, Hiroji Iwata, Stephen Chia, Peter A. Fasching, Adam Brufsky, Zbigniew Nowecki, Javier Pascual, Lionel Moreau, Shin-Cheh Chen, Nuri Karadurmus, Einav Nili Gal-Yam, Kyung Hae Jung, Sonia Pernas, Sasha McClain, Wei He, Teresa Klinowska, Cynthia Huang-Bartlett, Nicholas C. Turner
Read The Full Article at NEJM.
More posts featuring ASCO25.
Adam Brufsky
cancer
Cynthia Huang-Bartlett
Cynthia Ma
Einav Nili Gal-Yam
Erica L. Mayer
François-Clément Bidard
Giampaolo Bianchini
Harold J. Burstein
Hiroji Iwata
Javier Pascual
Kevin Kalinsky
Kyung Hae Jung
Lionel Moreau
Massimo Cristofanilli
Nicholas C. Turner
Nuri Karadurmus
OncoDaily
Oncology
Peter A. Fasching
Sasha McClain
Shin-Cheh Chen
Sonia Pernas.
Stephen Chia
Teresa Klinowska
Wei He
Wolfgang Janni
Yeon Hee Park
Zbigniew Nowecki
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 4, 2025, 17:02
Jun 4, 2025, 16:33
Jun 4, 2025, 16:33
Jun 4, 2025, 15:56